Julie M. Radeff, Ph.D.
Affiliations: | 2002 | Northwestern University, Evanston, IL |
Area:
Cell Biology, PharmacologyGoogle:
"Julie Radeff"Parents
Sign in to add mentor| Paula H. Stern | grad student | 2002 | Northwestern | |
| (Regulation of protein kinase C isozymes in osteoblasts by parathyroid hormone: Role for small G proteins.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Radeff JM, Nagy Z, Stern PH. (2004) Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 19: 1882-91 |
| Radeff JM, Singh AT, Stern PH. (2004) Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase Calpha and interleukin-6 in UMR-106 osteoblastic cells. Cellular Signalling. 16: 105-14 |
| Singh AT, Bhattacharyya RS, Radeff JM, et al. (2003) Regulation of parathyroid hormone-stimulated phospholipase D in UMR-106 cells by calcium, MAP kinase, and small G proteins. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 1453-60 |
| Dossing DA, Radeff JM, Sanders J, et al. (2001) Parathyroid hormone stimulates translocation of protein kinase C isozymes in UMR-106 osteoblastic osteosarcoma cells. Bone. 29: 223-30 |
| Radeff JM, Nagy Z, Stern PH. (2001) Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Experimental Cell Research. 268: 179-88 |
| Nagy Z, Radeff J, Stern PH. (2001) Stimulation of interleukin-6 promoter by parathyroid hormone, tumor necrosis factor alpha, and interleukin-1beta in UMR-106 osteoblastic cells is inhibited by protein kinase C antagonists. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 16: 1220-7 |
| Singh AT, Radeff JM, Kunnel JG, et al. (2000) Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochimica Et Biophysica Acta. 1487: 201-8 |